Overview

EMBL is Europe’s flagship life sciences laboratory that conducts basic molecular biology research and runs a wide network of over 80 independent research groups across six sites (Heidelberg, Barcelona, Hamburg, Grenoble, Rome, and EMBL-EBI Hinxton). It also provides scientific services to member states, trains scientists and students, develops new instruments and methods for the life sciences, and engages in technology transfer to share discoveries. Its work is carried out by an intergovernmental organization dedicated to advancing European life science research. EMBL supports researchers through access to facilities and services, training programs, and collaborative projects, while coordinating and integrating resources across Europe and fostering tech transfer. Its goal is to advance fundamental science, enable scientific progress across Europe, and strengthen the ecosystem of life science research and innovation through collaboration, training, and shared tools.

Simplify's Take

What believers are saying

• Boehringer Ingelheim Stiftung funds €7M in 2025, following €5M in 2017.
• Supported over 290 projects from 27 countries since mid-2021.
• Equipment donations from Zeiss, Leica, and Thermo Fisher equip latest microscopes.

What critics are saying

• BIS withdraws after €12M total, collapsing services in 36-48 months.
• Chan Zuckerberg Institute surpasses EMBL, diverting users in 12-24 months.
• Euro-BioImaging nodes fragment user base to Barcelona in 6-18 months.

What makes EMBL unique

• EMBL Imaging Centre pioneers open access to MINFLUX and cryo-electron tomography.
• Partnership with Leica Microsystems provides on-site experts for sample-prep.
• Plasma-FIB technology led by Julia Mahamid enables superior 3D FIB-SEM imaging.

Help us improve and share your feedback! Did you find this helpful?

YesNo